PanaMast SIGNED
Progressing a non-antibiotic antimicrobial treatment for Bovine Mastitis towards market - PanaMast
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0PanaMast project word cloud
Explore the words cloud of the PanaMast project. It provides you a very rough idea of what is the project "PanaMast" about.
Project "PanaMast" data sheet
The following table provides information about the project.
| Coordinator |
SLAINTE BEOGA TEORANTA
Organization address contact info |
| Coordinator Country | Ireland [IE] |
| Project website | http://www.westwayhealth.com |
| Total cost | 3˙549˙237 € |
| EC max contribution | 2˙484˙466 € (70%) |
| Programme |
1. H2020-EU.3.2.4. (Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy) 2. H2020-EU.3.2.1. (Sustainable agriculture and forestry) 3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 4. H2020-EU.3.2.2. (Sustainable and competitive agri-food sector for a safe and healthy diet) |
| Code Call | H2020-SMEINST-2-2016-2017 |
| Funding Scheme | SME-2 |
| Starting year | 2017 |
| Duration (year-month-day) | from 2017-06-01 to 2019-05-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | SLAINTE BEOGA TEORANTA | IE (GALWAY) | coordinator | 2˙484˙466.00 |
Map
Project objective
The world is facing an antibiotics crisis, with resistant bacteria rendering current treatments ineffective. Novel, effective solutions are urgently required for this $40bn global market. Westway Health (WWH) is based in Galway, Ireland, and is on track to become a leading veterinary antimicrobials company in the EU. It has developed an innovative, non-antibiotic technology, effective at killing all bacteria, including antibiotic-resistant bacteria like MRSA, while not inducing resistance. WWH’s lead product in development is PanaMastTM LC, a breakthrough treatment of bovine mastitis, the most economically important infectious disease affecting the dairy industry. PanaMastTM LC will represent a step change in the way that dairy farmers manage mastitis, which affects 30% of the herd annually. It will: 1. Be the world’s first non-antibiotic medicine for mastitis, offering superior clinical outcomes and significant financial gains to end-users (€150/case); 2. Reduce wastage of milk and culling of cows; (3) Improve profitability and environmental performance on European farms and dairy processing sites. The innovation directly addresses the major global problem of antibiotic resistance, while providing a sustainable animal health solution that supports production of safe and high quality food. The Phase 1 PanaMast project was successfully completed ahead of schedule and on budget. It allowed WWH to: 1. Develop a regulatory roadmap detailing all steps required to progress from current stage of development (TRL7) to first sale of commercial product (TRL8); 2. Develop a robust commercial exploitation plan for PanaMastTM LC in EU and global markets; 3. Establish key strategic relationships to assist commercialisation of PanaMastTM LC The Phase 1 results underpin this proposed project. The Phase 2 activities (pre-commercialisation/product development/product launch and commercialisation) are designed to ensure market launch and sale of PanaMastTM LC in the EU at TRL8 by 2020
Deliverables
| Project website | Websites, patent fillings, videos etc. | 2019-04-18 14:42:25 |
Take a look to the deliverables list in detail: detailed list of PanaMast deliverables.
Publications
| year | authors and title | journal | last update |
|---|---|---|---|
| 2018 |
Lilit Tonoyan, Aoife Boyd, Gerard T.A. Fleming, Ruairi Friel, Carol M. Gately, Paul H. Mc Cay, Vincent O\'Flaherty In vitro comparative cytotoxicity study of a novel biocidal iodo-thiocyanate complex published pages: 264-273, ISSN: 0887-2333, DOI: 10.1016/j.tiv.2018.03.014 |
Toxicology in Vitro 50 | 2019-06-11 |
| 2017 |
Lilit Tonoyan, Gerard T. A. Fleming, Paul H. Mc Cay, Ruairi Friel, Vincent O\'Flaherty Antibacterial Potential of an Antimicrobial Agent Inspired by Peroxidase-Catalyzed Systems published pages: , ISSN: 1664-302X, DOI: 10.3389/fmicb.2017.00680 |
Frontiers in Microbiology 8 | 2019-06-11 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PANAMAST" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PANAMAST" are provided by the European Opendata Portal: CORDIS opendata.